Table 3.

Antiproliferative activities of compounds 4.

Comp.	IC50 (μM)		Selectivity Ratio 1
	HepG2	LO2
4a	23.63	40.15	1.7
4b	23.41	65.29	2.79
4c	21.93	53.03	2.42
4d	36.34	248.39	6.84
4e	31.83	54	1.70
4f	3.03	49.47	16.33
4g	2.86	58.92	20.60
4h	20.74	82.34	3.97
4i	27.87	75.57	2.71
4j	12.58	36.37	2.89
4k	21.19	51.99	2.45
4l	17.29	78.6	4.55
4m	18.29	48.42	2.65
4n	7.9	49.9	6.32
TSA	23.85	65.29	2.74

¹ IC₅₀ (LO2)/IC₅₀ (HepG2).